Your browser is no longer supported. Please, upgrade your browser.
Settings
AMPE Ampio Pharmaceuticals, Inc. daily Stock Chart
AMPE [NYSE]
Ampio Pharmaceuticals, Inc.
Index- P/E- EPS (ttm)-0.42 Insider Own0.40% Shs Outstand86.32M Perf Week-1.28%
Market Cap199.40M Forward P/E- EPS next Y- Insider Trans0.00% Shs Float78.74M Perf Month26.23%
Income-27.90M PEG- EPS next Q- Inst Own19.20% Short Float18.74% Perf Quarter-19.23%
Sales- P/S- EPS this Y-123.00% Inst Trans0.15% Short Ratio19.84 Perf Half Y-20.89%
Book/sh-0.11 P/B- EPS next Y- ROA-213.20% Target Price14.00 Perf Year352.94%
Cash/sh0.09 P/C26.59 EPS next 5Y- ROE283.00% 52W Range0.38 - 4.95 Perf YTD-43.24%
Dividend- P/FCF- EPS past 5Y-18.40% ROI- 52W High-53.43% Beta-0.20
Dividend %- Quick Ratio2.20 Sales past 5Y- Gross Margin- 52W Low506.42% ATR0.18
Employees17 Current Ratio2.20 Sales Q/Q- Oper. Margin- RSI (14)54.97 Volatility5.99% 10.96%
OptionableYes Debt/Eq- EPS Q/Q898.70% Profit Margin- Rel Volume0.82 Prev Close2.31
ShortableYes LT Debt/Eq- Earnings- Payout- Avg Volume743.60K Price2.31
Recom- SMA208.24% SMA506.03% SMA2002.23% Volume283,781 Change-0.22%
Mar-17-14Reiterated Aegis Capital Buy $15 → $16
Sep-25-12Initiated Aegis Capital Buy $11
Jul-12-18 12:45PM  Ampio provides a Link to New Publication on the Mechanism of Action for Ampion PR Newswire
Jun-29-18 07:25AM  Free Pre-Market Technical Recap on Sarepta Therapeutics and Three Additional Biotech Stocks ACCESSWIRE
Jun-27-18 08:30AM  Ampio Reports New Publication on the Mechanisms of Action for Ampion PR Newswire
Jun-25-18 08:05AM  Today's Research Reports on Stocks to Watch: bluebird and Ampio Pharmaceuticals ACCESSWIRE
Jun-05-18 08:30AM  Ampio Provides Scientific Update and Links to Peer Review Publications PR Newswire
May-29-18 08:30AM  Ampio Updates Regulatory and IP Activities PR Newswire -13.17%
May-23-18 07:00AM  Free Daily Technical Summary Reports on Amicus Therapeutics and Three Other Biotech Stocks ACCESSWIRE +6.16%
May-22-18 08:30AM  Ampio Updates Scientific presentations and publications on Ampion PR Newswire -10.21%
May-14-18 08:30AM  Ampio Provides Corporate Update PR Newswire
May-02-18 08:30AM  The Pivotal Trial Results on Ampion (AP-003-C) Was Accepted for Publication in a Peer-Reviewed Medical Journal PR Newswire
May-01-18 02:02PM  Who Really Owns Ampio Pharmaceuticals Inc (NYSEMKT:AMPE)? Simply Wall St.
Apr-13-18 03:51PM  How Ampio Pharmaceuticals Inc (NYSEMKT:AMPE) Can Impact Your Portfolio Volatility Simply Wall St.
Apr-12-18 05:40PM  Ampio Updates Regulatory, Clinical and NYSE Activities PR Newswire
Apr-03-18 08:30AM  Ampio Updates Regulatory and Clinical Activities PR Newswire
Mar-29-18 08:25AM  New Research Coverage Highlights Apple Hospitality REIT, J.Jill, Benefitfocus, Ampio Pharmaceuticals, MFA Financial, and Del Frisco's Restaurant Group Consolidated Revenues, Company Growth, and Expectations for 2018 GlobeNewswire
Mar-26-18 08:30AM  Evidence for Delay of Total Knee Replacement (TKR) for Patients with Severe Osteoarthritis of the Knee Receiving Three Intra-articular (IA) Ampion Injections PR Newswire +5.46%
Mar-15-18 05:00PM  Ampio Pharmaceuticals Provides Corporate Update Following Conference Call PR Newswire
Mar-06-18 05:25PM  Ampio Hosting Conference Call, Wednesday, March 7, 5:00 pm EST PR Newswire
Feb-16-18 03:21PM  Here's Why Ampio Pharmaceuticals Dropped as Much as 18.8% Today Motley Fool -14.45%
Feb-13-18 02:39PM  Is Ampio Pharmaceuticals Inc (NYSEMKT:AMPE) Still A Cheap Healthcare Stock? Simply Wall St. +7.17%
Jan-26-18 07:30AM  Research Report Identifies Del Frisco's Restaurant Group, Capital Senior Living, Bazaarvoice, Macerich, Ampio Pharmaceuticals, and Diamondrock Hospitality with Renewed Outlook Fundamental Analysis, Calculating Forward Movement GlobeNewswire
Jan-22-18 03:00PM  Is Ampio Pharmaceuticals Incs (NYSEMKT:AMPE) CEO Salary Justified? Simply Wall St.
Jan-16-18 08:30AM  Ampio Update of J.P. Morgan Meeting Events and Disease Modification Discussions PR Newswire
Jan-15-18 02:51PM  What Does Ampio Pharmaceuticals Incs (NYSEMKT:AMPE) Ownership Structure Look Like? Simply Wall St.
Jan-08-18 08:30AM  Ampio Presentation at J.P. Morgan Healthcare Conference made available to all Shareholders PR Newswire
Jan-04-18 02:50PM  Did Ampio Pharmaceuticals Incs (NYSEMKT:AMPE) Recent Earnings Growth Beat The Trend? Simply Wall St. -16.61%
Jan-03-18 04:36PM  Here's Why Ampio Pharmaceuticals Sank as Much as 13.5% Today Motley Fool -13.51%
Dec-30-17 10:37AM  3 Biotech Stocks That Soared This Week: Are They Buys? Motley Fool
Dec-28-17 12:31PM  Why Ampio Pharmaceuticals Rose as Much as 15% Today Motley Fool +15.75%
Dec-14-17 11:29AM  Ampio Pharmaceuticals Inc (AMPE) Rallies as Knee Osteoarthritis Drug Findings Cheer SmarterAnalyst +33.14%
07:15AM  Ampio Pharmaceuticals Reports Positive Results for both Primary and Secondary Endpoints of Pivotal Phase 3 Trial of Ampion in Severe Osteoarthritis-of-the Knee (OAK) PR Newswire
Dec-04-17 08:10AM  Todays Research Reports on Stocks to Watch: Ampio Pharmaceuticals and Versartis ACCESSWIRE
Nov-30-17 08:00AM  Ampio Pharmaceuticals Announces Engagement of LaVoieHealthScience for Integrated Public and Investor Relations PR Newswire -24.86%
Nov-24-17 08:00AM  Todays Research Reports on Stocks to Watch: Ampio Pharmaceuticals and Agenus Inc. ACCESSWIRE +13.71%
Nov-22-17 08:30AM  Ampio Announces Publication of Ampion Treatment of Severe Osteoarthritis of the Knee as a Feature Article in Orthopedics Peer-Reviewed Journal PR Newswire +27.74%
Nov-16-17 06:25PM  Ampio Pharmaceuticals, Inc. Announces Continued Listing Plan Accepted by NYSE American PR Newswire +8.94%
Nov-15-17 08:30AM  Ampio Announces Start of Open Label Extension Study to Support Commercial Label of Repeat Administration of Ampion in Severe Osteoarthritis of the Knee PR Newswire
Oct-18-17 10:30PM  Ampio Pharmaceuticals, Inc. Announces Closing of Registered Direct Offering PR Newswire +15.67%
Oct-16-17 08:30AM  Ampio Pharmaceuticals, Inc. Announces Pricing of Registered Direct Offering PR Newswire -13.36%
Oct-13-17 08:00AM  Todays Research Reports on Stocks to Watch: Ampio Pharmaceuticals and Ardelyx Inc. ACCESSWIRE
Oct-12-17 08:30AM  Ampio Announces Accepted Publication of Pooled Ampion Clinical Trial Results in Patients with Severe Osteoarthritis of the Knee PR Newswire +26.70%
Sep-18-17 08:30AM  Ampio Completes Enrollment of Patients in 12-Week Pivotal Trial PR Newswire +6.73%
Sep-08-17 08:00AM  Ampio Pharmaceuticals, Inc. Announces Annual Shareholder Meeting PR Newswire
Sep-07-17 07:35PM  Ampio Pharmaceuticals, Inc. to Present at the 19th Annual Rodman & Renshaw Global Investment Conference PR Newswire
04:10PM  Ampio Discloses Receipt of Notice from NYSE American and Has Until March 1, 2019, to Gain Compliance PR Newswire
Aug-08-17 08:30AM  Ampio Announces the Allowance of a Composition and Methods Patent in the USA Using Ampion in Conjunction with Stem Cells PR Newswire
Jul-06-17 01:55PM  Ampio Hosting Conference Call, Wednesday, July 12, 4:30 pm EDT PR Newswire
Jun-22-17 08:30AM  Ampio Injects First Patient in Final Pivotal Clinical Trial for Ampion BLA PR Newswire
Jun-12-17 08:30AM  Ampio Announces Appointment of Interim Chief Financial Officer PR Newswire
Jun-07-17 07:20PM  Ampio Pharmaceuticals, Inc. Announces Closing of Registered Direct Offering PR Newswire
Jun-02-17 12:16PM  Ampio Pharmaceuticals, Inc. Announces Pricing of Registered Direct Offering PR Newswire -19.71%
May-05-17 08:00AM  Ampion Human Macrophage Study Results Accepted for Presentation at the 2017 Annual AAST Meeting in Baltimore PR Newswire +16.36%
May-01-17 08:00AM  Ampio Initiates Pivotal Trial of Ampion PR Newswire +28.98%
Apr-24-17 08:00AM  The Rosen Law Firm, P.A. Announces Proposed Class Action Settlement on Behalf of Purchasers of Common Stock of Ampio Pharmaceuticals, Inc. -- AMPE GlobeNewswire
Mar-28-17 08:32AM  AMPIO PHARMACEUTICALS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and
08:00AM  Ampio Pharmaceuticals Amends Warrant Agreement PR Newswire
Mar-23-17 04:28PM  Colorado biotech's accountants express 'substantial doubt' about firm's future at bizjournals.com
04:28PM  Colorado biotech's accountants express 'substantial doubt' about firm's future American City Business Journals
08:30AM  Ampio Updates Intellectual Property and Regulatory Exclusivity Strategy to Support the Commercialization of Ampion PR Newswire
Mar-22-17 04:05PM  Update - Ampio Pharmaceuticals Provides Corporate Update PR Newswire
01:04PM  AMPIO PHARMACEUTICALS, INC. Financials
Mar-20-17 08:30AM  Ampio Pharmaceuticals Provides Corporate Update PR Newswire
Mar-16-17 04:23PM  AMPIO PHARMACEUTICALS, INC. Files SEC form 10-K, Annual Report
Mar-13-17 05:29PM  AMPIO PHARMACEUTICALS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Change in Directors or Pr
Mar-01-17 08:05AM  Ampio Hosting Conference Call Tuesday, March 7, 4:30pm EST PR Newswire +5.91%
Feb-27-17 08:30AM  Ampio Receives Guidance from the FDA and Proposes a Path for Approval for Single-Injection Ampion for the Treatment of Pain Due to Severe Osteoarthritis of the Knee PR Newswire +5.45%
Jan-10-17 04:06PM  AMPIO PHARMACEUTICALS, INC. Files SEC form 8-K, Submission of Matters to a Vote of Security Holders
Nov-10-16 08:05AM  Ampio Updates Clinical and Regulatory Activity PR Newswire
Nov-08-16 08:09AM  AMPIO PHARMACEUTICALS, INC. Files SEC form 10-Q, Quarterly Report
Oct-04-16 08:30AM  Ampio Announces Accepted Publication of the Clinical Trial Results of Its Oral Drug, Optina, Treatment of Diabetic Macular Edema PR Newswire
Sep-29-16 02:50PM  Ampio Updates Clinical and Regulatory Activity PR Newswire
Sep-08-16 12:08PM  Ampio Reports Peer-Reviewed Publication on the Potential use of Ampion in New Clinical Indications PR Newswire
Aug-30-16 08:00AM  Ampio Reports Additional Peer-Reviewed Publication on Ampion PR Newswire
Aug-29-16 05:29PM  AMPIO PHARMACEUTICALS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and -8.85%
11:07AM  Ampio Pharmaceuticals, Inc. Announces Pricing of Registered Direct Offering PR Newswire
Aug-03-16 08:00AM  Ampio Updates Regulatory Status of AMPION PR Newswire
06:20AM  Ampio reports 2Q loss
Aug-02-16 04:09PM  AMPIO PHARMACEUTICALS, INC. Files SEC form 10-Q, Quarterly Report
Jul-13-16 07:17AM  7 Stocks Under $10 That Could Make You a Lot of Money TheStreet.com
07:17AM  7 Stocks Under $10 That Could Make You a Lot of Money
Jul-05-16 01:30PM  Ampio Hosting Conference Call Today, July 5, 4:30pm ET PR Newswire
08:00AM  Answering Two Most Important Questions Surrounding Ampio Pharmaceuticals Inc (AMPE) at Insider Monkey
Jul-03-16 09:35AM  4 Companies That Destroyed Shareholders Despite a Brexit Recovery at 24/7 Wall St.
Jun-30-16 03:57PM  Why Ampio Pharma (AMPE) Stock Is Plummeting Today
01:42PM  Ampio Crashes After Late-Stage Trial Failure
08:38AM  Ampio Pharma stock plummets 55% after negative late-stage trial results at MarketWatch
08:38AM  Ampio Pharma stock plummets 55% after negative late-stage trial results at MarketWatch
08:05AM  AMPIO PHARMACEUTICALS, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits
08:00AM  Ampio announces results of Ampion trials PR Newswire
May-10-16 08:30AM  Ampio Launches Clinical Trial of AMPION for the Treatment of Osteoarthritis of the Hand PR Newswire
May-06-16 09:07AM  AMPIO PHARMACEUTICALS, INC. Files SEC form 10-Q, Quarterly Report
May-03-16 08:30AM  Ampio Reports Additional Peer-Reviewed Publications on Ampion PR Newswire
Mar-29-16 04:45PM  AMPIO PHARMACEUTICALS, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits
09:19AM  Ampio Completes Enrollment in Pivotal Clinical Trial of AMPION March 29, 2016 at noodls
09:03AM  Ampio Completes Enrollment in Pivotal Clinical Trial of AMPION PR Newswire
Mar-07-16 04:45PM  AMPIO PHARMACEUTICALS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Change in Directors or Pr
Feb-26-16 09:25AM  AMPIO PHARMACEUTICALS, INC. Files SEC form 10-K, Annual Report
Feb-11-16 07:30AM  Ampio Clarifies ATM Program PR Newswire
Feb-10-16 04:46PM  AMPIO PHARMACEUTICALS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Other Events, Financial S
Jan-29-16 09:02AM  AMPIO PHARMACEUTICALS, INC. Files SEC form 8-K, Regulation FD Disclosure
Ampio Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of therapies for the treatment of prevalent inflammatory conditions in the United States. The company is developing compounds that decrease inflammation by inhibiting specific pro-inflammatory compounds by affecting specific pathways at the protein expression and at the transcription level; activating specific phosphatase or depleting available phosphate needed for the inflammation process; and decreasing vascular permeability. Its product pipeline includes Ampion, an intra-articular injection for the treatment of osteoarthritis of the knee; and Optina, an oral agent for the treatment of diabetic macular edema. Ampio Pharmaceuticals, Inc. is headquartered in Englewood, Colorado.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
COELHO PHILIP HDirectorSep 27Buy0.6310,0006,270104,727Sep 28 05:15 PM
COELHO PHILIP HDirectorSep 22Buy0.603,0001,80094,727Sep 22 06:56 PM
COELHO PHILIP HDirectorSep 20Buy0.591,00059291,727Sep 22 06:56 PM
COELHO PHILIP HDirectorSep 19Buy0.5715,0008,51990,727Sep 21 03:30 PM